Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03406910 · ClinicalTrials.gov registry record
Egg Intake and Risk of Type 2 Diabetes
A clinical trial, sponsored by Loma Linda University.
- Completed
- Registry status
- 55,851
- Enrollment target
NCT03406910: Completed study, sponsored by Loma Linda University.
NCT03406910 is a clinical trial that has completed, run by Loma Linda University. The registered enrollment target is 55,851 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03406910 has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- 55,851 participants
- Enrollment target
Study Summary
This is a longitudinal study that will collect demographic, anthropometric and dietary data to determine the relationships between meat and egg intake and the incidence of Type 2 Diabetes.
Primary Outcome
Validated quantitative food frequency questionnaire that compares risk of T2D in subjects who consume different frequencies /amounts of egg and meat and physician diagnosis of diabetes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55,851 participants |
| Start Date | 2015-02-13 |
| Est. Completion | 2017-06-30 |
What the finished NCT03406910 record still lists
NCT03406910 is an observational study that tracks outcomes without assigning an intervention. Its 55,851 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03406910 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03406910 about?
NCT03406910 is a clinical study titled "Egg Intake and Risk of Type 2 Diabetes". This is a longitudinal study that will collect demographic, anthropometric and dietary data to determine the relationships between meat and egg intake and the incidence of Type 2 Diabetes.
What is the current status of trial NCT03406910?
This trial is currently completed. The enrollment target is 55,851 participants. The study started on 2015-02-13. Estimated completion is 2017-06-30.
Who is sponsoring clinical trial NCT03406910?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07224243 · 54,000 participants · NA
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
- NCT05975671 · 52,500 participants · NA
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
- NCT06355934 · 52,121 participants
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
- NCT00785525 · 60,000 participants · Phase 3
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI